Cory Lewis

Cory Lewis is the CEO, President, Founder, and Board Member of INCOG BioPharma Services, a company he founded in June 2020.1 INCOG BioPharma offers development and manufacturing services to biopharmaceutical companies, specializing in areas such as analytical method development, process scale-up, and formulation/filling of biopharmaceuticals.1

Professional Background

Prior to founding INCOG BioPharma, Cory Lewis had an extensive career in the pharmaceutical and biotechnology industries:

• He served as Vice President and General Manager of Catalent Biologics—Drug Product at Catalent Pharma Solutions from March 2018 to February 2019.1
• Before that, he was Vice President of Business Operations at Catalent Pharma Solutions from October 2017 to March 2018.1
• From April 2009 to October 2017, he held the position of Vice President of Business Development and Marketing at Cook Pharmica.1

Education

Cory Lewis holds the following educational qualifications:

• Master of Business Administration from Northwestern University - Kellogg School of Management (2006-2007)1
• Bachelor of Science in Finance from Indiana University Bloomington (1992-1996)1

Achievements

Under Cory's leadership at Cook Pharmica, the company grew from a start-up to a market-leading CDMO, resulting in a $950 million acquisition by Catalent Pharma Solutions in October 2017.1 Throughout his career, he has been responsible for overseeing business relationships with numerous biopharmaceutical companies, contributing to the growth of clinical pipelines and commercial approvals.1

At INCOG BioPharma, Cory leads a team with significant industry experience. The executive leadership team has collectively guided over 200 different molecules through manufacturing scale-up for clinical production and assisted biopharma customers in launching more than 50 commercially approved therapeutics.2